IRIS
ALBERTELLI, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.346
Totale 5.346
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.346
Totale 5.346
Salva come PNG Salva come JPEG
Città #
Genova 3.658
Genoa 622
Rapallo 595
Vado Ligure 452
Bordighera 19
Totale 5.346
Salva come PNG Salva come JPEG
Nome #
SOMATOSTATIN AND DOPAMINE RECEPTOR INTERACTION IN PROSTATE AND LUNG CANCER CELL LINES 179
Autonomic nervous system and cardiovascular risk assessment during one year of growth hormone (GH) replacement therapy in adults with GH deficiency. 158
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 147
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study 146
Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system 145
Diabetes secondary to neuroendocrine gastroenteropancreatic tumors 145
Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors 137
Preclinical and clinical experiences with the role of dopamine receptors in the treatment of pituitary adenomas 136
Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation 130
Grade increases in gastroenteropancreatic neuroendocrine tumor metastases compared to the primary tumor 130
Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives 127
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 125
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? 125
Twenty years of gastroenteropancreatic neuroendocrine tumors: is reclassification worthwhile and feasible? 121
Emerging targets in pituitary adenomas: role of the CXCL12/CXCR4-R7 system 120
One-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients 120
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: effect of mono- and bi-specific somatostatin analogs on cell growth. 119
KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment ? 117
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures 117
Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients 113
Ectopic Cushing and other paraneoplastic syndromes in thoracic neuroendocrine tumors 111
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study 108
Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies 107
Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms 103
Somatostatin receptor pathophysiology in the neuroendocrine system 103
Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review 102
Role of dopamine receptors in normal and tumoral pituitary corticotropic cells and adrenal cells 101
Doe4s biopsy reliably identify grade in gastro-entero-pancreatic neuroendocrine tumors? 99
Ten years of gastroeneteropancreatic neuroendocrine tumors: is reclassification Worth while? 98
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study 98
Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly 97
Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study 96
Hormone and Receptor Candidates for Target and Biotherapy of Neuroendocrine Tumors 95
The treatment of hyperinsulinemic hypoglycaemia in adults: an update 88
"Present and future of immunotherapy in Neuroendocrine Tumors" 85
Potential indications for somatostatin analogues: immune system and lymphoproliferative disorders 84
Does biopsy reliably identify grade in gastro-entero-pancreatic neuroendocrine tumors? 76
Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study 73
Ki-67 heterogeneity in gastroenteropancreatic neuroendocrine tumors 70
Erratum to: KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment? (Endocrine, (2017), 57, 3, (494-502), 10.1007/s12020-017-1364-8) 62
Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study 62
Body Composition and Bone Status in Relation to Microvascular Damage in Systemic Sclerosis Patients 59
GOSAFE - Geriatric Oncology Surgical Assessment and Functional rEcovery after Surgery: early analysis on 977 patients 52
Insights into mechanisms of tumorigenesis in neuroendocrine neoplasms 51
Nuove potenziali applicazioni degli analoghi della somatostatina 50
PD-L1 expression, BRAF and TERT mutation in a cohort of aggressive thyroid cancers: case series from a single-centre experience 49
A tool to predict survival in stage IV entero-pancreatic NEN 49
The effect of sodium restriction on iodine prophylaxis: a review 47
PRRT: identikit of the perfect patient 44
GH Replacement in the Elderly: Is It Worth It? 44
Sodium Intake and Target Organ Damage in Hypertension-An Update about the Role of a Real Villain 40
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? 39
2-[18 F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study 39
Modulatory activity of testosterone on growth pattern and IGF-1 levels in vanishing testis syndrome: a case report during 15 years of follow-up 38
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 37
Rectal mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN): High grade evolution of a MANET? 29
Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose 27
Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis 27
Nonconventional Doses of Somatostatin Analogs in Patients with Progressing Well-Differentiated Neuroendocrine Tumor 25
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study 25
Possible protective role of metformin therapy on colonic polyps in acromegaly: An exploratory cross-sectional study 24
Potential indications for somatostatin analogues: immune system and limphoproliferative disorders 19
Current perspectives in obesity management: unraveling the impact of different therapy approach in real life obesity care 19
An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report 16
Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study 15
Trabecular Bone Score as a Reliable Measure of Lumbar Spine Bone Microarchitecture in Acromegalic Patients 13
Off-label pasireotide treatment in one insulinoma patient with an atypical presentation and intolerant to diazoxide 13
Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies 12
Bone metastases in neuroendocrine neoplasms: From pathogenesis to clinical management 10
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study 10
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties 8
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel 8
Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask 7
Open issues on G3 neuroendocrine neoplasms: Back to the future 4
The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience 3
Totale 5.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.269
article - articoli 19.877
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 392
Totale 40.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.019 0 0 0 0 115 128 183 94 114 206 140 39
2020/2021548 34 50 42 56 73 26 25 56 52 60 46 28
2021/2022661 37 22 39 80 12 70 24 154 52 70 21 80
2022/2023717 68 81 15 54 93 97 16 62 114 8 101 8
2023/2024528 26 69 6 66 39 96 39 30 13 31 45 68
2024/2025481 51 96 56 139 139 0 0 0 0 0 0 0
Totale 5.527